Biosensors for early diagnosis and automated drug delivery in pancreatic cancer

Abstract

Pancreatic cancer remains one of the most challenging malignancies to diagnose and treat effectively, resulting in poor patient outcomes due to late-stage detection and limited therapeutic options. The emergence of biosensors has revolutionized cancer diagnosis and therapy, providing new avenues for early detection and personalized treatment. This paper explores the development and integration of biosensors within a unique expert system for pancreatic cancer diagnosis and drug delivery automation. It discusses the principles, types, and applications of biosensors in pancreatic cancer diagnosis, their role in automating drug delivery, and the design of an expert system that leverages these technologies to enhance patient outcomes.